Mammography Biopsy Chair Market, by Product Type (Electric, Manual), by Feature (Reclining, Non-Reclining), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Others (Cancer Research Institutes, etc.)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Mammography is specialized medical imaging technique in which a low-dose x-ray system utilized to view within the breasts. A mammogram, also known as a mammography examination, helps women with the early detection and diagnosis of breast disorders. Doctors use x-ray examinations to identify and treat medical disorders. To capture images of the inside of the body, a small amount of ionizing radiation is exposed to human body. The earliest and most used type of medical imaging is x-ray. Digital mammography, computer-aided detection, and breast tomosynthesis are three new mammography advancements.
A biopsy procedure includes removal of tissue from any part of the body to diagnose a disease. A suspected nodule or lump may be surgically removed by some, while others may take a small sample of tissue using a needle to perform biopsy. Mammography biopsy chair is a versatile option for mammography, radiology, and transportation. The Mammography biopsy chair's ability to change positions from a chair to a fully reclined position is intended to make it easy to position and treat patients.
Market Dynamics
Breast cancer is a condition in which the breast's cells proliferate in irregular manner. There are different types of breast cancer. Breast tissue is sampled during a breast biopsy in order to be tested to perform disease diagnosis.
There is a great demand for mammography biopsy chairs due the larger patient pool of breast cancer across the globe, which is expected to drive global mammography biopsy chair market during the forecast period.
For instance, according to the data provided by the American Society of Clinical Oncology (ASCO) in 2022, it is estimated that 51,400 women in the U.S. are expected to be diagnosed with non-invasive (in situ) breast cancer.
Moreover, according to the data provided by the Breast Cancer Research Foundation, it is estimated that around 287,850 women will be diagnosed with breast cancer in the U.S. in the year 2022.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook